REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q4 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $590,245 | +22.3% | 3,712 | +8.8% | 0.00% | 0.0% |
| Q2 2023 | $482,661 | +1.1% | 3,412 | +20.3% | 0.00% | 0.0% |
| Q1 2023 | $477,469 | -41.6% | 2,836 | -41.3% | 0.00% | 0.0% |
| Q4 2022 | $818,275 | -15.8% | 4,833 | -7.0% | 0.00% | -50.0% |
| Q3 2022 | $972,000 | +11.6% | 5,195 | -3.2% | 0.00% | 0.0% |
| Q2 2022 | $871,000 | -17.7% | 5,366 | -4.6% | 0.00% | 0.0% |
| Q1 2022 | $1,058,000 | -41.9% | 5,622 | -18.3% | 0.00% | -33.3% |
| Q4 2021 | $1,821,000 | -14.3% | 6,878 | -6.4% | 0.00% | 0.0% |
| Q3 2021 | $2,124,000 | +77.0% | 7,347 | +22.2% | 0.00% | +50.0% |
| Q2 2021 | $1,200,000 | +13.4% | 6,011 | +10.4% | 0.00% | 0.0% |
| Q1 2021 | $1,058,000 | +4.3% | 5,444 | +2.9% | 0.00% | 0.0% |
| Q4 2020 | $1,014,000 | +50.2% | 5,292 | +15.8% | 0.00% | +100.0% |
| Q3 2020 | $675,000 | +11.6% | 4,570 | -6.4% | 0.00% | 0.0% |
| Q2 2020 | $605,000 | +10.8% | 4,885 | -13.6% | 0.00% | 0.0% |
| Q1 2020 | $546,000 | -0.5% | 5,654 | -4.8% | 0.00% | 0.0% |
| Q4 2019 | $549,000 | +47.6% | 5,939 | +22.7% | 0.00% | -83.3% |
| Q3 2019 | $372,000 | -32.4% | 4,841 | -24.4% | 0.01% | -40.0% |
| Q2 2019 | $550,000 | +39.9% | 6,405 | -3.8% | 0.01% | +42.9% |
| Q1 2019 | $393,000 | +13.3% | 6,660 | +1.1% | 0.01% | 0.0% |
| Q4 2018 | $347,000 | -12.8% | 6,585 | -8.2% | 0.01% | 0.0% |
| Q3 2018 | $398,000 | +11.5% | 7,170 | -5.5% | 0.01% | 0.0% |
| Q2 2018 | $357,000 | +24.0% | 7,585 | -4.8% | 0.01% | +40.0% |
| Q1 2018 | $288,000 | +1.1% | 7,965 | +1.5% | 0.01% | 0.0% |
| Q4 2017 | $285,000 | -5.6% | 7,845 | -0.4% | 0.01% | -16.7% |
| Q3 2017 | $302,000 | -9.6% | 7,875 | -2.3% | 0.01% | -14.3% |
| Q2 2017 | $334,000 | +16.4% | 8,060 | -1.1% | 0.01% | +16.7% |
| Q1 2017 | $287,000 | +8.7% | 8,150 | -4.8% | 0.01% | +20.0% |
| Q4 2016 | $264,000 | +1.1% | 8,565 | -0.8% | 0.01% | 0.0% |
| Q3 2016 | $261,000 | +8.3% | 8,635 | -2.0% | 0.01% | 0.0% |
| Q2 2016 | $241,000 | – | 8,815 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |